Our evaluation framework is based on the internationally accepted evaluation framework of the Organization for Economic Co-operation and Development’s Development Assistance Committee, including its principles and criteria for grant evaluations. The framework was updated in 2022 to align with our 2023-2027 Strategy.

We require at least one evaluation for each investment or portfolio of investments, typically conducted within 12 months of closure. We also conduct prospective evaluations to facilitate real-time learning and thematic evaluations to review performance and capture learning within cross-cutting areas of our strategic framework.

Our evaluations are an integral part of the results framework, which provides more information on the tools and methods we use to quantify our impact.

Upcoming evaluations

1. End-of-project evaluation of our investment in Perennial Malaria Chemoprevention (PMC), (Ref. link: https://www.ungm.org/Public/Notice/260555)
2. Mid-Term Review of Unitaid’s 2023-2027 Strategy (Ref. link: RFP 2024.16 Mid-Term Review of Unitaid’s 2023-2027 Strategy)
3. Review of Unitaid’s scalability approach: challenges and opportunities (Ref. link: RFP 2024.17 Review of Unitaid’s scalability approach: challenges and opportunities)
4. End-of-Grant Evaluation – Medicines Patent Pool (MPP III), (Ref. link: https://www.ungm.org/Public/Notice/257052)